Clinical Trials
3 trialsNCT06880523 2026-04-14
SLIDE-HCC
Canadian Cancer Trials Group
Phase 2 Recruiting
NCT06068153 2024-11-20
AMBER
ETOP IBCSG Partners Foundation
Phase 2 Withdrawn
NCT03005015 2016-12-29
Lenvatinib in Second Line Endometrial Carcinoma
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Withdrawn